Search
for
Sort by
Research 61–90 of 325
- Lithium therapy associated with hidradenitis suppurativa: Case report and a review of the dermatologic side effects of lithium
- Toxic shock syndrome: Recent developments in pathogenesis
- Incidence of adverse cutaneous drug reactions in a Mexican sample: an exploratory study on their association to tumour necrosis factor alpha TNF2 allele
- Cutaneous Reactions to Drugs
- Pattern of Cutaneous Manifestations in Systemic Lupus Erythematosus: A Cross-Sectional Hospital-Based Study
- Manifestaciones dermatológicas por Covid-19 y su aporte en la comprensión de la enfermedad
- Cutaneous manifestations of COVID-19
- A study of cutaneous manifestations of systemic lupus erythematosus in Malwa region of India
- Dermatolojik Problemler ve COVID-19
- Cutaneous manifestations of HIV infection other than Kaposi's sarcoma: Clinical and histologic aspects
- Drug reaction with eosinophilia and systemic symptoms and severe involvement of digestive tract: description of two cases
- Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects
- Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique
- Enanthem in Patients With COVID-19 and Skin Rash
- Dermatologic Conditions of the Early Post-Transplant Period in Hematopoietic Stem Cell Transplant Recipients
- The Case ∣ Fever, rash, and positive Ehrlichia antibodies
- Cutaneous manifestations and considerations in COVID ‐19 pandemic: A systematic review
- Epidermal Growth Factor Receptor Inhibitors: A Review of Cutaneous Adverse Events and Management
- Cutaneous manifestations associated with immune checkpoint inhibitors
- Cutaneous Toxicities of Advanced Treatment for Cutaneous Melanoma: A Prospective Study from a Single-Center Institution
- Skin, mucosa and nail findings in hospitalized pediatric patients with Coronavirus disease-2019 (COVID-19)
- Prominent Cutaneous Manifestation of COVID-19: A Case Report
- Rare and common manifestations of COVID‐19 in children
- First-in-Man Clinical Trial of the Oral Pan-AKT Inhibitor MK-2206 in Patients With Advanced Solid Tumors
- RASopathic Skin Eruptions during Vemurafenib Therapy
- Cutaneous manifestations of COVID-19: a systematic review and analysis of individual patient-level data
- Dermatologic Effects of Selumetinib in Pediatric Patients with Neurofibromatosis Type 1: Clinical Challenges and Therapeutic Management
- Adult Kawasaki's disease with myocarditis, splenomegaly, and highly elevated serum ferritin levels
- Cutaneous Adverse Events of Tyrosine Kinase Inhibitors in Endocrine Tumors: Clinical Features, Mechanisms, and Management Strategies
- Skin Manifestations of Rheumatological Diseases